Mid-regional proadrenomedullin: An early marker of response in critically ill patients with severe community-acquired pneumonia?
Background: Mid-regional proadrenomedullin (MR-proADM) is a novel biomarker with potential prognostic utility in patients with community-acquired pneumonia (CAP). Purpose: To evaluate the value of MR-proADM levels at ICU admission for further severity stratification and outcome prediction, and its k...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2016-11-01
|
| Series: | Revista Portuguesa de Pneumologia (English Edition) |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2173511516300185 |